Jan. 30, 2024Other news to note for Jan. 30, 2024Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent, Alpha-9, Arcus, Avrobio, Bridgebio Can-Fite, Cidara, Concentra, Cormedix, Ewopharma, Fabentech, Gilead, Incyte, Invitae, Ionis, ITM, J&J, Maxcyte, Mundipharma, Nanobio, Qubit, Tetonic, Theseus, Vaxxinity, Vect-Horus, Wugen.
Jan. 30, 2024Other news to note for Jan. 30, 2024Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 410 Medical, Aditxt, Agilent, Aion Labs, Alpha-9, Autonomix, BD, Brain Scientific, Icecure, Impulse Medical, Incyte, ITM Isotope, Lonza, Oxford Nanopore, Microbot Medical, Nanobiotix, Navinci, Techcyte, Vector Laboratories.
Jan. 30, 2024Other news to note for Jan. 30, 2024Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Sun Pharmaceutical, Substipharm, Taro Pharmaceuticals, Zuellig.